Biotechnology in India: Regulation, Policy and Ethics

Prerequisites

• Agricultural Biotechnology — GM crops and genome-edited rice, which these rules govern.
• Medical Biotechnology — therapies and vaccines that need approval.
• Biodiversity and Conservation — the Convention on Biological Diversity framework.

The Hook: Whose Neem, Whose Turmeric?

Why it matters: Prelims asks “GEAC is under which ministry”, “Cartagena Protocol deals with…”, “BioE3 stands for…”. Mains P-IV asks you to evaluate India’s biotech regulation or discuss bioethics; GS-V (P-VII) touches the international treaties.

India’s Biosafety Framework

The legal base is the “Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms, Genetically Engineered Organisms or Cells, 1989” (the Rules of 1989), framed under the Environment (Protection) Act, 1986.

graph TD
    A["RDAC
Recombinant DNA Advisory Committee (DBT)
reviews developments, advises"] --> B
    B["IBSC
Institutional Biosafety Committee
in every institution doing GE research"] --> C["RCGM
Review Committee on Genetic Manipulation (DBT)
research, confined trials"]
    C --> D["GEAC
Genetic Engineering Appraisal Committee (MoEFCC)
large-scale use and environmental release"]
    D --> E["SBCC and DLC
State Biotechnology Coordination Committee,
District Level Committee: monitoring"]

Other regulators: FSSAI — GM food (Section 22, Food Safety and Standards Act, 2006); CDSCO under the Drugs Controller General of India — vaccines, biologicals, gene and cell therapies; ICMR — guidelines for biomedical research, stem cells and gene therapy; Protection of Plant Varieties and Farmers’ Rights Authority — plant varieties and farmers’ rights (PPV&FR Act, 2001).

International Agreements

India is a party to the CBD and both main protocols. India’s domestic law for the CBD is the Biological Diversity Act, 2002 (amended in 2023), administered by the National Biodiversity Authority (Chennai), State Biodiversity Boards and Biodiversity Management Committees.

Biopiracy and Traditional Knowledge

Biopiracy (जैव-दस्यु) is the use of biological resources or traditional knowledge, often through patents, without authorisation or fair benefit-sharing with the communities or countries concerned.

India’s response: the Traditional Knowledge Digital Library (TKDL), created by CSIR with the Ministry of AYUSH (from 2001), documents traditional formulations in patent-office formats so examiners can find prior art; the Biological Diversity Act requires approval for access to bioresources and benefit-sharing; the Geographical Indications regime protects names such as Basmati.

Institutions and Policy

Bioethics: The Core Questions

Analysis for Mains: Is India’s Biotech Regulation Fit for Purpose?

Way forward (for answers): a single, independent, statutory biotech regulator (the earlier BRAI Bill proposal lapsed); public biosafety data; a national GM crop policy as directed by the Supreme Court; capacity for SBCCs and DLCs; benefit-sharing that reaches tribal knowledge-holders.

Memory Tricks

Don’t Confuse

Common Mistakes

Practice

All questions below are original practice questions written in CGPSC style. They are not previous-year questions.

Level 1: Foundation

1. GEAC functions under the Ministry of ______.
2. The international agreement on safe transboundary movement of living modified organisms is the ______ Protocol.
3. In “BioE3”, the three Es stand for Economy, Environment and ______.

Level 2: Prelims MCQs

Q1. Consider the following statements:

1. The Rules of 1989 governing genetically engineered organisms were framed under the Environment (Protection) Act, 1986.
2. The Review Committee on Genetic Manipulation (RCGM) functions under the Ministry of Environment, Forest and Climate Change.
3. The Nagoya Protocol deals with access to genetic resources and the fair sharing of benefits from their use.

Which of the statements given above is/are correct?

• (a) 1 only
• (b) 2 and 3 only
• (c) 1 and 3 only
• (d) 1, 2 and 3

Q2. Match List I with List II:

• (a) A-2, B-1, C-3, D-4
• (b) A-2, B-1, C-4, D-3
• (c) A-1, B-2, C-4, D-3
• (d) A-4, B-1, C-2, D-3

Q3. The BioE3 policy approved by the Union Cabinet in August 2024 primarily aims to:

• (a) Regulate the import of GM foods
• (b) Promote high-performance biomanufacturing for economy, environment and employment
• (c) Replace the Biological Diversity Act
• (d) Create a national DNA data bank

Q4. Which of the following patents, based on Indian traditional knowledge, was revoked after a challenge led by CSIR in 1997?

• (a) Neem-based fungicide in Europe
• (b) Wound-healing use of turmeric in the USA
• (c) Basmati rice lines in the USA
• (d) Darjeeling tea trademark in Japan

Level 3: Mains Answer Writing

Q1. (60 words) What is biopiracy? How has India responded to it?

Q2. (150–200 words) Critically examine India’s regulatory framework for genetically modified organisms. What reforms are needed?

Quick Revision Table

Key Takeaways

What’s Next

• Biotechnology — Quick Revision — the whole chapter on one page
• Biodiversity and Conservation — CBD, biodiversity hotspots and conservation laws
• International Organisations — WTO, UN bodies and treaties
• Forests and Wildlife of Chhattisgarh — the bioresources these laws protect